We congratulate researchers at MedH who have been awarded CIMED project grants for the period 2027-2029.
The following researchers at MedH have been awarded project grants from CIMED.
Junior:
Antonino Cassotta – “Dissecting the myeloma-reactive TCR repertoire to develop predictive models of clinical response to T cell engager therapy”
Catarina Lindqvist – “Nourishing the failing liver: nutrition support across the full spectrum of liver disease”
Ying Shang – “GLP-1 receptor agonists in metabolic dysfunction-associated steatotic liver disease: who to treat, for how long, and how safe is it?
Jakob Theorell – “Finding, understanding and treating autoimmune encephalitides”
Maarten van de Klundert – “Improvement of clinical care of persons living with HIV through implementation of and advanced diagnostic tool of drug resistance minor viral variants in the HIV reservoir”
Erik von Seth – “Strictures and malignancy in the biliary tree – improving prognosis in primary sclerosing cholangitis”
Axel Wester – “Chronic liver disease – risk stratification and pharmacotherapy”
Senior:
Soo Aleman – “Kliniska, immunologiska, virologiska och mikrobiom-relaterade faktorer vid svår postcovid”
Marcus Buggert – “Development and functional evaluation of mRNA-LNP-mediated CAR T cells for B cell-driven disease”
Roland Fiskesund – “From Blood Bank to Immunotherapy: A Non-Expanded Pooled NK Cell Product for Rapid NK DLI in AML and High Risk MDS (RAPID NK = Rapid Allogeneic Pooled Immunotherapy Development – NK)”
Sara Gredmark Russ – “Host Immunomodulation and Its Influence on TBE Risk and Outcomes: Foundations for Monoclonal Antibody Based Prophylaxis and Treatment”
Petter Höglund – “Etiology, pathogenesis and diagnostics of autoimmune neutropenia”
Martin Jädersten – “SAMHD1 as a targetable resistance factor in acute myeloid leukemia”
Hans-Gustaf Ljunggren – “Korsreaktiv immunitet mot potentiellt hotande zoonotiska coronavirus efter SARS-CoV-2 mRNA vaccination hos friska individer och patienter med immunbrist”
Isabelle Magalhaes – “Identification of cytotoxic, persistent CAR T cells for ovarian cancer treatment”
Emma Svennberg – “Waiting on Atrial fibrillation Intervention Therapy (WAIT) Study”
Ylva Trolle Lagerros – ” Bibehålla muskelmassa vid GLP-1-analogbehandling: från cell till intervention”
-(1).jpg?sfvrsn=d9b3751f_3)
